17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

          C-reactive protein (CRP) predicts risk of myocardial infarction (MI) and stroke among apparently healthy men, but in women, virtually no data are available. CRP was measured in baseline blood samples from 122 apparently healthy participants in the Women's Health Study who subsequently suffered a first cardiovascular event and from 244 age- and smoking-matched control subjects who remained free of cardiovascular disease during a 3-year follow-up period. Women who developed cardiovascular events had higher baseline CRP levels than control subjects (P=0.0001), such that those with the highest levels at baseline had a 5-fold increase in risk of any vascular event (RR=4.8; 95% CI, 2.3 to 10.1; P=0.0001) and a 7-fold increase in risk of MI or stroke (RR=7.3; 95% CI, 2.7 to 19.9; P=0.0001). Risk estimates were independent of other risk factors, and prediction models that included CRP provided a better method to predict risk than models that excluded CRP (all P values <0.01). In stratified analyses, CRP was a predictor among subgroups of women with low as well as high risk as defined by other cardiovascular risk factors. In these prospective data among women, CRP is a strong independent risk factor for cardiovascular disease that adds to the predictive value of risk models based on usual factors alone. (Circulation. 1998;98:731-733.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            World Health Organization definition of myocardial infarction: 2008-09 revision.

            WHO has played a leading role in the formulation and promulgation of standard criteria for the diagnosis of coronary heart disease and myocardial infarction since early 1970s. The revised definition takes into consideration the following: well-resourced settings can use the ESC/ACC/AHA/WHF definition, which has new biomarkers as a compulsory feature; in resource-constrained settings, a typical biomarker pattern cannot be made a compulsory feature as the necessary assays may not be available; the definition must also have provision for diagnosing non-fatal events with incomplete information on cardiac biomarkers and the ECG; to facilitate epidemiologic monitoring definition must recognize fatal events with incomplete or no information on cardiac biomarkers and/or ECG and/or autopsy and/or coronary angiography. Category A definition is the same as ESC/ACC/AHA/WHF definition of MI, and can be applied to settings with no resource constraints. Category B definition of MI is to be applied whenever there is incomplete information on cardiac bio-markers together with symptoms of ischaemia and the development of unequivocal pathological Q waves. Category C definition (probable MI) is to be applied when individuals with MI may not satisfy Category A or B definitions because of delayed access to medical services and/or unavailability of electrocardiography and/or laboratory assay of cardiac biomarkers. In these situations, the term probable MI should be used when there is either ECG changes suggestive of MI or incomplete information on cardiac biomarkers in a person with symptoms of ischaemia with no evidence of a non-coronary reason. This article presents the 2008-09 revision of the World Health Organization (WHO) definition of myocardial infarction (MI) developed at a WHO expert consultation.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Production of C-reactive protein and risk of coronary events in stable and unstable angina

                Bookmark

                Author and article information

                Journal
                Scandinavian Cardiovascular Journal
                Scandinavian Cardiovascular Journal
                Informa UK Limited
                1401-7431
                1651-2006
                April 08 2019
                March 04 2019
                April 03 2019
                March 04 2019
                : 53
                : 2
                : 83-90
                Affiliations
                [1 ] Department of Cardiology, Health Sciences University, Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey;
                [2 ] Department of Cardiology, Kafkas University Medical Faculty, Kars, Turkey;
                [3 ] Department of Cardiology, Kars Harakani State Hospital, Kars, Turkey;
                [4 ] Department of Internal Medicine, Kafkas University Medical Faculty, Kars, Turkey;
                [5 ] Department of Cardiology, Ataturk University Medical School, Erzurum, Turkey
                Article
                10.1080/14017431.2019.1590628
                30835559
                2333ec39-28b3-4c6c-93cd-505feb72aa35
                © 2019
                History

                Comments

                Comment on this article